| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Peyer | 10% Owner | 2025-12-09 | 2,666 | $7.95 | $21.19kSell |
| James Peyer | 10% Owner | 2025-12-09 | 395 | $8.04 | $3.18kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 3,105 | $8.59 | $26.67kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 2,666 | $7.95 | $21.19kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 395 | $6.40 | $2.53kBuy |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 395 | $8.04 | $3.18kSell |
| Cambrian Biopharma Inc | 10% Owner | 2025-12-09 | 446 | $7.92 | $3.53kSell |
| James Peyer | 10% Owner | 2025-12-09 | 446 | $7.92 | $3.53kSell |
| James Peyer | 10% Owner | 2025-12-09 | 395 | $6.40 | $2.53kBuy |
| James Peyer | 10% Owner | 2025-12-08 | 3,105 | $8.59 | $26.67kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James Peyer | 423.65% | 5,343,479 | $45.79M | Insider |
| Hs Investments I LP | 350.91% | 4,425,998 | $37.93M | Insider |
| Thomas G. Ricks | 54.36% | 685,632 | $5.88M | Insider |
| Cambrian Biopharma Inc | 12.30% | 155,142 | $1.33M | Insider |
| John Celebi | 8.39% | 105,862 | $907.24k | Insider |
| Robert Hamilton Pierce | 7.49% | 94,463 | $809.55k | Insider |
| Erin Colgan | 5.35% | 67,462 | $578.15k | Insider |
| Der Horst Edward Van | 4.74% | 59,794 | $512.43k | Insider |
| Patrick Stephen Gallagher | 2.71% | 34,130 | $292.49k | Insider |
| Bob Holmen | 2.03% | 25,598 | $219.37k | Insider |